|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 763.00 BDT | -0.07% |
|
-1.48% | +7.77% |
| Market Cap | 1.83B 14.91M 12.85M 11.83M 11.11M 20.86M 1.41B 21.08M 140M 54.47M 690M 55.95M 54.77M 2.39B | P/E Ratio 2024 |
189x | P/E Ratio 2025 | 369x |
|---|---|---|---|---|---|
| Enterprise Value | 2.34B 19.03M 16.4M 15.1M 14.18M 26.62M 1.8B 26.91M 178M 69.53M 881M 71.42M 69.91M 3.05B | EV / Sales 2024 |
10.4x | EV / Sales 2025 | 10.7x |
| Free-Float |
22.75% | Yield 2024 |
0.13% | Yield 2025 | 0.12% |
| 1 day | -0.07% | ||
| 1 week | -1.48% | ||
| Current month | -1.93% | ||
| 1 month | -2.03% | ||
| 3 months | -0.55% | ||
| 6 months | +4.33% | ||
| Current year | +7.77% |
| 1 week | 755 |  | 800 |
| 1 month | 755 | | 819 |
| Current year | 689 | | 821 |
| 1 year | 681 | | 929 |
| 3 years | 511 | | 1,302.3 |
| 5 years | 375.3 | | 1,302.3 |
| 10 years | 281.4 | | 1,302.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Director of Finance/CFO | - | - | |
| Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | - | |
| Director/Board Member | - | - | |
Nurjehan Hudda
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.07% | -1.48% | -0.57% | +45.06% | 14.92M | |
| -0.29% | +0.67% | +6.69% | +82.18% | 45.85B | |
| +1.27% | -1.80% | +42.88% | +87.04% | 33.63B | |
| -0.59% | -1.06% | -8.77% | +37.57% | 11.81B | |
| -0.86% | -0.82% | +10.64% | +96.43% | 11.59B | |
| 0.00% | +3.12% | +40.43% | +132.60% | 9.28B | |
| -1.73% | +0.59% | +18.63% | +41.79% | 7.33B | |
| -0.26% | +0.49% | +44.71% | -15.55% | 6.65B | |
| +0.00% | -0.91% | +29.15% | +235.70% | 6.44B | |
| -3.10% | -2.79% | -44.79% | -6.76% | 5.16B | |
| Average | -0.56% | -0.49% | +13.90% | +73.61% | 13.77B | |
| Weighted average by Cap. | -0.13% | -0.37% | +18.40% | +81.12% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 219M 1.79M 1.54M 1.42M 1.33M 2.5M 169M 2.52M 16.74M 6.52M 82.67M 6.7M 6.56M 286M | 231M 1.88M 1.62M 1.49M 1.4M 2.63M 177M 2.65M 17.6M 6.86M 86.91M 7.04M 6.9M 301M |
| Net income | 9.68M 78.84K 67.95K 62.57K 58.75K 110K 7.45M 111K 739K 288K 3.65M 296K 290K 12.65M | 5.31M 43.23K 37.25K 34.31K 32.21K 60.47K 4.09M 61.11K 405K 158K 2M 162K 159K 6.94M |
| Net Debt | 445M 3.62M 3.12M 2.87M 2.7M 5.06M 342M 5.12M 33.95M 13.23M 168M 13.59M 13.3M 581M | 506M 4.12M 3.55M 3.27M 3.07M 5.77M 390M 5.83M 38.66M 15.06M 191M 15.47M 15.14M 661M |
Employees
474
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-15 | 763.00 BDT | -0.07% | 2,253 |
| 26-06-15 | 763.50 BDT | -1.55% | 736 |
| 26-06-14 | 775.50 BDT | +2.16% | 880 |
| 26-06-11 | 759.10 BDT | -2.72% | 2,326 |
| 26-06-10 | 780.30 BDT | +0.23% | 3,868 |
- Stock Market
- Stocks
- AMBEEPHA Stock
Select your edition
All financial news and data tailored to specific country editions
